摘要
目的观察冠心病患者口服通心络治疗后血脂浓度变化及血浆内皮素(ET-1)浓度的变化。方法将70例冠心病不稳定型心绞痛患者随机分为治疗组(35例)和对照组(35例),二组基础治疗相同,治疗组在对照组基础治疗上加服通心络胶囊,治疗4周后观察二组患者内皮素及血脂变化。结果与对照组比较,治疗组降低内皮素(ET-1)、血脂疗效更为显著。结论通心络胶囊治疗冠心病患者可有效调节内皮素的水平,改善内皮功能。
Objective To observe the change of blood fats density and blood plasma endothelin 1（ET-1） density in coronary disease patient who takes orally Tong-Xin-Luo capsule.Methods 70 coronary disease stability mode angina pectoris patient were randomly divided into treated group（35 cases） and control group（35 cases）.All patients of two groups were administered same foundational medicine,the patients took plus Tong-Xin-Lou capsule in the treated group.After the treatment all around（4 weeks）,the change of blood fats density and blood plasma endothelin 1（ET-1） density was observed in two groups.Results Compared with the control group,the level of blood fats and blood plasma endothelin 1（ET-1） was reduced remarkably in the treated group.Conclusion Tong-Xin-Luo capsule is possible to adjust the level of blood plasma endothelin 1 and improve endothelial function for coronary disease patient.
出处
《中国煤炭工业医学杂志》
2011年第11期1583-1586,共4页
Chinese Journal of Coal Industry Medicine
关键词
不稳定型心绞痛
血管内皮功能
通心络胶囊
instability angina pectoris
endothelial function
Tong-Xin-Luo capsule
